Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases

Details for Australian Patent Application No. 2004200705 (hide)

Owner Imclone Systems Incorporated

Inventors Robert, Francisco; Waksal, Harlan W; Saleh, Mansoor N; Buchsbaum, Donald Jay

Agent Baldwin Shelston Waters

Pub. Number AU-A-2004200705

Parent 40799

Filing date 23 February 2004

Wipo publication date 18 March 2004

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

11 March 2004 Complete Application Filed

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2004200705

25 March 2004 Corrigenda

  Complete Applications Filed - Name Index Under the name Imclone Systems Incorporated, Application No. 2004200705, Under INID (71) correct the applicant names to read Imclone Systems Incorporated and UAB Research Foundation.

8 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200706-A method of strengthening of moulds

2004200704-Metallic implants having roughened surfaces and method for producing the same